Wojciech Jurczak - Dept Hematol, Jagiellonian Univ

基本信息

浏览量：159

职业迁徙

个人简介

W. Jurczak currently works at Polish Naval Academy. W. Jurczak does research in Naval Engineering, Mechanical Engineering and Materials Engineering. Their current project is 'w.jurczak@amw.gdynia.pl'.

研究兴趣

论文共 620 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Bispecific Antibodies in Relapsed/refractory Diffuse Large B-cell Lymphoma

Michał Danecki,Wojciech Jurczak

Acta Haematologica Polonica（2024）

引用0浏览0引用

Higher Mortality in Patients with Diffuse Large B-cell Lymphoma Pre-Existing Arterial Hypertension—Real World Data of the Polish Lymphoma Research Group

Sebastian Szmit,Monika Dlugosz-Danecka,Joanna Drozd-Sokolowska,Monika Joks,Agnieszka Szeremet,Artur Jurczyszyn,Wojciech Jurczak

HEART LUNG AND CIRCULATIONno. 5 (2024): 675-683

引用0浏览0WOS引用

Abstract 3732: Peripheral Pharmacodynamic Activity of Epcoritamab As Monotherapy and in Combination with Rituximab + Lenalidomide in Patients with Follicular Lymphoma

Han Si,Jimin Zhang,Monica Wielgos-Bonvallet,Lorenzo Falchi,Kim Linton,Wojciech Jurczak,David Belada,Isil Altintas,Mariana Sacchi,Elena Favaro,Ali Rana,Daniela Hoehn,David Soong,Christopher W. Chiu,Maria Jure-Kunkel

CANCER RESEARCHno. 6 (2024)

引用0浏览0引用

Biomarker Analysis of the ASPEN Study Comparing Zanubrutinib with Ibrutinib for Patients with Waldenström Macroglobulinemia

Constantine S. Tam,Stephen Opat,Shirley D'Sa,Wojciech Jurczak,Hui-Peng Lee,Gavin Cull,Roger G. Owen,Paula Marlton,Bjoern E. Wahlin,Ramon Garcia-Sanz,Helen McCarthy,Stephen Mulligan,Alessandra Tedeschi,Jorge J. Castillo,Jaros law Czyz,Carlos Fernandez De Larrea,David Belada,Edward Libby,Jeffrey Matous,Marina Motta,Tanya Siddiqi,Monica Tani,Marek Trneny,Monique C. Minnema, Christian Buske,Veronique Leblond,Steven P. Treon,Judith Trotman, Binghao Wu, Yiling Yu, Zhirong Shen, Wai Y. Chan, Jingjing Schneider,Heather Allewelt,Aileen Cohen,Meletios A. Dimopoulos

Blood advancesno. 7 (2024): 1639-1650

引用0浏览0WOS引用

The PI3Kδ Inhibitor Zandelisib on Intermittent Dosing in Relapsed/refractory Follicular Lymphoma: Results from a Global Phase 2 Study

Andrew D. Zelenetz,Wojciech Jurczak,Vincent Ribrag,Kim Linton,Graham P. Collins, Javier L. Jimenez,Mark Bishton,Bhagirathbhai Dholaria,Andrea Mengarelli,Tycel J. Phillips, Nagendraprasad Sungala,Gerardo Musuraca,Oonagh Sheehy, Eric Van Den Neste,Mitsuhiko Odera, Lu Miao,Daniel P. Gold,Richard G. Ghalie,Pier L. Zinzani

HEMASPHEREno. 8 (2024)

引用0浏览0WOS引用

EPCORE NHL-1 Follicular Lymphoma (FL) Cycle (C) 1 Optimization (OPT) Cohort: Expanding the Clinical Utility of Epcoritamab in Relapsed or Refractory (R/R) FL

Julie Vose,Umberto Vitolo,Pieternella Lugtenburg,Martine E. D. Chamuleau,Kim M. Linton, Catherine Thieblemont,Kristina Sonnevi,Wojciech Jurczak,Adam J. Olszewski,Farrukh Tauseef Awan, Craig Y. Okada,Tatyana A. Feldman,Martin Hutchings,Elena Favaro,Daniela Hoehn, Zhu Li,Rebekah Conlon,Juan-Manuel Sancho,Julio C. Chavez

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Acalabrutinib-based Regimens in Frontline or Relapsed/refractory Higher-Risk CLL: Pooled Analysis of 5 Clinical Trials

Matthew S. Davids,Jeff P. Sharman,Paolo Ghia,Jennifer A. Woyach,Toby A. Eyre,Wojciech Jurczak,Tanya Siddiqi,Paulo Miranda,Mina Shahkarami,Anna Butturini,Ugochinyere Emeribe,John C. Byrd

BLOOD ADVANCESno. 13 (2024): 3345-3359

引用0浏览0WOS引用

Acalabrutinib Plus Venetoclax and Rituximab in Treatment-Naive Mantle Cell Lymphoma: 2-Year Safety and Efficacy Analysis

Michael Wang,Tadeusz Robak,Kami J. Maddocks,Tycel Phillips,Stephen D. Smith,David Gallinson,Roser Calvo,Chuan-Chuan Wun,Veerendra Munugalavadla,Wojciech Jurczak

Blood advancesno. 17 (2024): 4539-4548

引用0浏览0WOS引用

Mutational Profile of Previously Treated Chronic Lymphocytic Leukemia Patients Progressing on Acalabrutinib or Ibrutinib

Jennifer A. Woyach,Daniel Jones,Wojciech Jurczak,Tadeusz Robak,Arpad Illes,Arnon P. Kater,Paolo Ghia,John C. Byrd,John F. Seymour,Susan Long,Nehad Mohamed,Samon Benrashid,Tzung-Huei Lai,Gary De Jesus, Richard Lai,Gerjan de Bruin,Simon Rule,Veerendra Munugalavadla

BLOODno. 10 (2024): 1061-1068

引用0浏览0WOS引用

Abstract 5071: Minimal Residual Disease (MRD) Status by Peripheral Blood Mononuclear Cells (pbmcs) and Circulating Tumor DNA (ctdna) Demonstrates Rapid, Deep, and Sustained Response in Patients (pts) with Relapsed/refractory Follicular Lymphoma (R/R FL) Treated with Subcutaneous (SC) Epcoritamab Monotherapy in the Pivotal Phase ..

David Soong,Işıl Altıntaş, John Karavitis,Kim M. Linton,Wojciech Jurczak,Catherine Thieblemont, Kevin Zhao,Edith Szafer-Glusman,Daniela Hoehn,Elena Favaro,Mariana Sacchi,Maria Jure-Kunkel

Cancer Researchno. 6_Supplement (2024): 5071-5071

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn